CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Von Seebach against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 24, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Dosage Regimen For A S1P Receptor AgonistNOVARTISMar 3, 2021
Dosage Regimen For A S1P Receptor AgonistNOVARTISAug 18, 2020
Apixaban FormulationsBRISTOL MYERS SQUIBB IRELANDAug 6, 2020

Top competitors of Von Seebach

List of top competitors of Von Seebach based on patent oppositions.